Genomics in Michigan to AdJust Outcomes in Prostate canceR (G-MAJOR) for Men With Newly Diagnosed Favorable Risk Prostate Cancer

计划入组 805 人 · 首次发布于 2020 年 5 月 21 日

Decipher Genomics Resource for Intelligent Discovery

计划入组 1,000,000 人 · 首次发布于 2015 年 11 月 20 日

Decipher Lethal Prostate Cancer Biology - Urine Metabolomics

计划入组 2,000 人 · 首次发布于 2017 年 8 月 2 日

VPS34 inhibitors(Deciphera Pharmaceuticals/Sprint Biosciences)

Undisclosed,Deciphera(GCN2,Solid Tumors,GCN2 Activator)

Deciphera Pharmaceuticals, Inc.

United States

Deciphera Pharmaceuticals, LLC

United States

Deciphera Pharmaceuticals (Netherlands) Bv

Belgium

Decipher Genomic Test Predicts Chemotherapy Benefit in Metastatic Prostate Cancer

Decipher Genomic Classifier Shows Promise for Predicting Prostate Cancer Treatment Outcomes

Veracyte Expands Decipher Prostate Test to Metastatic Cancer Patients, Offering New Treatment Guidance Tool